All In MedTech

Device Trial Radar · NCT07292779

A Prospective Clinical Investigation of DMFI150 for Treating Nasolabial Folds

A Prospective, Clinical Investigation to Evaluate the Performance and Safety of DMFI150 for the Treatment of Nasolabial Folds

Last checked: Nov 20, 2026Latest source record: Mar 5, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

30

Planned (sponsor's estimate)

Start

Nov 24, 2025

Primary completion

Dec 2026

Study completion Dec 2026

Sponsor

Lead sponsor
Samyang Biopharmaceuticals CorporationNot on our public-company list
Sponsor type
Industry
First posted
Dec 18, 2025

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 18 years, up to 70 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a prospective clinical investigation designed to evaluate the performance and safety of DMFI150 for the treatment of nasolabial folds. 30 adult participants will receive a single treatment with the investigational device. The study will assess wrinkle severity using validated aesthetic evaluation scales, as well as overall safety.

Conditions

  • Nasolabial Folds, Wrinkles

Interventions

  • DMFI150Device

    Injection of DMFI150 for nasolabial folds.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change from Baseline in Wrinkle Severity Rating Scale (WSRS) as Assessed by the Evaluator Investigator (EI)Time frame: Baseline to Month 12

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Ocean Clinic

    Marbella, Spain · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.